CD8A and COVID-19: UPPHI likely have different repertoires of protective and pathogenic memory CD4+ and CD8+ T cells targeting cross-reactive CCCs/SARS-CoV-2 epitopes of structural, non-structural, and accessory protein antigens that are associated with different disease outcomes in COVID-19 patients (13, 67–69).